ResMed demonstrated strong financial and operational performance in Q2 2025, supported by double-digit growth across key segments and expanding gross margins. The AirSense 11 platform and AirTouch ...

up 11% year over year. Furthermore, the company's Residential Care Software segment saw an 8% increase due to the adoption of digital solutions in homecare settings. ResMed’s adjusted gross ...

(RTTNews) - Resmed Inc (RMD) revealed a profit for its second quarter that increased from last year and beat the Street estimates. The company's earnings totaled $344.6 million, or $2.34 per share.

CSL Ltd (ASX: CSL) and ResMed Inc (ASX: RMD) shares are popular blue chip options for investors. But are they in the buy zone right now? Let's take a look at what one leading broker is saying ...

Led by growth in the U.S., ResMed’s first half achieved 12 per cent revenue growth over the same period last year, with devices and masks both growing by 11 per cent in constant currency terms during ...